Catalyst pharmaceuticals, inc. (CPRX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Product revenue, net

102,306

500

0

0

0

0

0

0

-

488

-

Operating costs and expenses:
Cost of sales

14,759

-

-

-

-

-

-

-

-

-

-

Research and development

18,842

19,919

11,375

11,369

11,801

10,117

8,096

2,659

3,383

2,306

5,097

Selling, general and administrative

36,881

15,875

7,304

7,910

8,597

4,473

2,214

2,561

2,698

2,206

2,177

Total operating costs and expenses

70,483

35,795

18,679

19,280

20,398

14,591

10,311

5,221

6,082

4,513

7,275

Operating income (loss)

31,823

-35,295

-18,679

-19,280

-20,398

-14,591

-10,311

-5,221

-6,082

-4,024

-7,275

Other income, net

1,585

1,291

454

321

100

76

47

14

10

17

33

Change in fair value of warrants liability

-

-

186

-886

-65

993

1,890

-1,129

319

-

-

Net income (loss) before income taxes

33,409

-34,003

-18,412

-18,072

-20,232

-15,509

-12,154

-4,076

-6,391

-4,006

-7,241

Provision for income taxes

1,533

-

0

0

0

0

0

0

0

0

0

Net income (loss)

31,875

-34,003

-18,412

-18,072

-20,232

-15,509

-12,154

-4,076

-6,391

-4,006

-7,241

Net income (loss) per share:
Basic

0.31

-0.33

-

-

-

-

-

-

-

-

-

Diluted

0.30

-0.33

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding:
Basic

102,944

102,633

-

-

-

-

-

-

-

-

-

Diluted

106,020

102,633

-

-

-

-

-

-

-

-

-

Net loss per share - basic and diluted

-

-

-0.21

-0.22

-0.25

-0.24

-0.27

-0.14

-0.29

-0.22

-0.48

Weighted average shares outstanding - basic and diluted

-

-

85,802

82,875

80,858

64,142

45,452

30,033

21,728

18,580

15,066

Net income (loss)

31,875

-34,003

-18,412

-

-

-

-

-

-

-

-

Other comprehensive income (loss):
Unrealized gain (loss) on available-for-sale securities

29

-20

-

-

-

-

-

-

-

-

-

Comprehensive income (loss)

31,905

-34,023

-18,412

-

-

-

-

-

-

-

-

Product [Member]
Revenues

102,306

-

-

-

-

-

-

-

-

-

-

Collaborative Arrangement Product Agreement [Member]
Revenues

0

500

-

-

-

-

-

-

-

-

-